121 related articles for article (PubMed ID: 28667740)
1. Functional melanoma-risk variant IRF4 rs12203592 associated with Breslow thickness: a pooled international study of primary melanomas.
Gibbs DC; Ward SV; Orlow I; Cadby G; Kanetsky PA; Luo L; Busam KJ; Kricker A; Armstrong BK; Cust AE; Anton-Culver H; Gallagher RP; Zanetti R; Rosso S; Sacchetto L; Ollila DW; Begg CB; Berwick M; Thomas NE;
Br J Dermatol; 2017 Nov; 177(5):e180-e182. PubMed ID: 28667740
[No Abstract] [Full Text] [Related]
2. Association of Interferon Regulatory Factor-4 Polymorphism rs12203592 With Divergent Melanoma Pathways.
Gibbs DC; Orlow I; Bramson JI; Kanetsky PA; Luo L; Kricker A; Armstrong BK; Anton-Culver H; Gruber SB; Marrett LD; Gallagher RP; Zanetti R; Rosso S; Dwyer T; Sharma A; La Pilla E; From L; Busam KJ; Cust AE; Ollila DW; Begg CB; Berwick M; Thomas NE;
J Natl Cancer Inst; 2016 Jul; 108(7):. PubMed ID: 26857527
[TBL] [Abstract][Full Text] [Related]
3. IRF4 rs12203592*T/T genotype is associated with nodular melanoma.
Rayner JE; McMeniman EK; Duffy DL; De'Ambrosis B; Smithers BM; Jagirdar K; Lee KJ; Soyer HP; Sturm RA
Melanoma Res; 2019 Aug; 29(4):445-446. PubMed ID: 31246726
[No Abstract] [Full Text] [Related]
4. IRF4 rs12203592 functional variant and melanoma survival.
Potrony M; Rebollo-Morell A; Giménez-Xavier P; Zimmer L; Puig-Butille JA; Tell-Marti G; Sucker A; Badenas C; Carrera C; Malvehy J; Schadendorf D; Puig S
Int J Cancer; 2017 Apr; 140(8):1845-1849. PubMed ID: 28103633
[TBL] [Abstract][Full Text] [Related]
5. Association of IRF4 single-nucleotide polymorphism rs12203592 with melanoma-specific survival.
Ward SV; Gibbs DC; Orlow I; Thomas NE; Kanetsky PA; Luo L; Cust AE; Anton-Culver H; Gruber SB; Gallagher RP; Rosso S; Zanetti R; Dwyer T; Begg CB; Berwick M;
Br J Dermatol; 2020 Jul; 183(1):163-165. PubMed ID: 31958143
[No Abstract] [Full Text] [Related]
6. Cell-type-specific meQTLs extend melanoma GWAS annotation beyond eQTLs and inform melanocyte gene-regulatory mechanisms.
Zhang T; Choi J; Dilshat R; Einarsdóttir BÓ; Kovacs MA; Xu M; Malasky M; Chowdhury S; Jones K; Bishop DT; Goldstein AM; Iles MM; Landi MT; Law MH; Shi J; Steingrímsson E; Brown KM
Am J Hum Genet; 2021 Sep; 108(9):1631-1646. PubMed ID: 34293285
[TBL] [Abstract][Full Text] [Related]
7. IRF4 variants have age-specific effects on nevus count and predispose to melanoma.
Duffy DL; Iles MM; Glass D; Zhu G; Barrett JH; Höiom V; Zhao ZZ; Sturm RA; Soranzo N; Hammond C; Kvaskoff M; Whiteman DC; Mangino M; Hansson J; Newton-Bishop JA; ; Bataille V; Hayward NK; Martin NG; Bishop DT; Spector TD; Montgomery GW
Am J Hum Genet; 2010 Jul; 87(1):6-16. PubMed ID: 20602913
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis of the Correlation Between Interleukin-6 Promoter Polymorphism -174G/C and Interferon Regulatory Factor 4 rs12203592 Polymorphism With Skin Cancer Susceptibility.
Wu M; Cao Y; Liu YL; Ma LL; Yang XH
Am J Ther; 2016; 23(6):e1758-e1767. PubMed ID: 26928068
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms in nevus-associated genes MTAP, PLA2G6, and IRF4 and the risk of invasive cutaneous melanoma.
Kvaskoff M; Whiteman DC; Zhao ZZ; Montgomery GW; Martin NG; Hayward NK; Duffy DL
Twin Res Hum Genet; 2011 Oct; 14(5):422-32. PubMed ID: 21962134
[TBL] [Abstract][Full Text] [Related]
10. Genetic variation in IRF4 expression modulates growth characteristics, tyrosinase expression and interferon-gamma response in melanocytic cells.
Chhabra Y; Yong HXL; Fane ME; Soogrim A; Lim W; Mahiuddin DN; Kim RSQ; Ashcroft M; Beatson SA; Ainger SA; Smit DJ; Jagirdar K; Walker GJ; Sturm RA; Smith AG
Pigment Cell Melanoma Res; 2018 Jan; 31(1):51-63. PubMed ID: 28755520
[TBL] [Abstract][Full Text] [Related]
11. IRF4 SNP is predictive of melanoma subtypes.
Granovetter M
Lancet Oncol; 2016 Mar; 17(3):e96. PubMed ID: 26907189
[No Abstract] [Full Text] [Related]
12. The association of host and genetic melanoma risk factors with Breslow thickness in the Western Australian Melanoma Health Study.
Cadby G; Ward SV; Cole JM; Moses EK; Millward M; Palmer LJ
Br J Dermatol; 2014 Apr; 170(4):851-7. PubMed ID: 24405011
[TBL] [Abstract][Full Text] [Related]
13. Association of interferon regulatory factor 4 gene polymorphisms rs12203592 and rs872071 with skin cancer and haematological malignancies susceptibility: a meta-analysis of 19 case-control studies.
Wang S; Yan Q; Chen P; Zhao P; Gu A
BMC Cancer; 2014 Jun; 14():410. PubMed ID: 24906573
[TBL] [Abstract][Full Text] [Related]
14. Genetic variants in PARP1 (rs3219090) and IRF4 (rs12203592) genes associated with melanoma susceptibility in a Spanish population.
Peña-Chilet M; Blanquer-Maceiras M; Ibarrola-Villava M; Martinez-Cadenas C; Martin-Gonzalez M; Gomez-Fernandez C; Mayor M; Aviles JA; Lluch A; Ribas G
BMC Cancer; 2013 Mar; 13():160. PubMed ID: 23537197
[TBL] [Abstract][Full Text] [Related]
15. Allele-specific transcriptional regulation of IRF4 in melanocytes is mediated by chromatin looping of the intronic rs12203592 enhancer to the IRF4 promoter.
Visser M; Palstra RJ; Kayser M
Hum Mol Genet; 2015 May; 24(9):2649-61. PubMed ID: 25631878
[TBL] [Abstract][Full Text] [Related]
16. IL28B polymorphism cannot predict response to interferon alpha treatment in patients with melanoma.
Probst M; Hoeller C; Ferenci P; Staettermayer AF; Beinhardt S; Pehamberger H; Kittler H; Grabmeier-Pfistershammer K
PLoS One; 2014; 9(11):e112613. PubMed ID: 25389973
[TBL] [Abstract][Full Text] [Related]
17. Association of Melanoma-Risk Variants with Primary Melanoma Tumor Prognostic Characteristics and Melanoma-Specific Survival in the GEM Study.
Davari DR; Orlow I; Kanetsky PA; Luo L; Busam KJ; Sharma A; Kricker A; Cust AE; Anton-Culver H; Gruber SB; Gallagher RP; Zanetti R; Rosso S; Sacchetto L; Dwyer T; Gibbs DC; Ollila DW; Begg CB; Berwick M; Thomas NE
Curr Oncol; 2021 Nov; 28(6):4756-4771. PubMed ID: 34898573
[TBL] [Abstract][Full Text] [Related]
18. A novel polymorphism in the 1A promoter region of the vitamin D receptor is associated with altered susceptibilty and prognosis in malignant melanoma.
Halsall JA; Osborne JE; Potter L; Pringle JH; Hutchinson PE
Br J Cancer; 2004 Aug; 91(4):765-70. PubMed ID: 15238985
[TBL] [Abstract][Full Text] [Related]
19. Melanoma Expression Genes Identified through Genome-Wide Association Study of Breslow Tumor Thickness.
Fang S; Vaysse A; Brossard M; Wang Y; Deng D; Liu Q; Zhang P; Xu K; Li M; Feng R; Liu H; Dang Y; Chen W; Prieto V; Gershenwald JE; Ross MI; Matejka B; Malke J; Haydu LE; Reveille JD; Sui D; Bassett RL; Koshkina N; Avril MF; Lu M; Wei Q; Demenais F; Amos CI; Lee JE
J Invest Dermatol; 2017 Jan; 137(1):253-257. PubMed ID: 27506587
[No Abstract] [Full Text] [Related]
20. Nuclear morphometry, immunohistochemical staining with Ki-67 antibody and mitotic index in the assessment of proliferative activity and prognosis of primary malignant melanomas of the skin.
Talve LA; Collan YU; Ekfors TO
J Cutan Pathol; 1996 Aug; 23(4):335-43. PubMed ID: 8864921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
